MUFG Americas’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,383
Closed -$62K – 896
2022
Q2
$62K Hold
1,383
– – ﹤0.01% 489
2022
Q1
$78K Hold
1,383
– – ﹤0.01% 485
2021
Q4
$72K Buy
+1,383
New +$71.3K ﹤0.01% 498
2018
Q4
– Sell
-779
Closed -$48K – 747
2018
Q3
$48K Hold
779
– – ﹤0.01% 520
2018
Q2
$42K Hold
779
– – ﹤0.01% 561
2018
Q1
$35K Sell
779
-239
-23% -$10.2K ﹤0.01% 561
2017
Q4
$40K Buy
+1,018
New +$38.7K ﹤0.01% 599
2015
Q2
– Sell
-20
Closed -$1K – 1180
2015
Q1
$1K Buy
+20
New +$684 ﹤0.01% 1115
2013
Q3
– Sell
-4,582
Closed -$105K – 1248
2013
Q2
$105K Buy
+4,582
New +$104K ﹤0.01% 1022

Other funds holding EHC

MUFG Americas's EHC Position: Q3 2022 in Review

MUFG Americas sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 1,383 shares — an estimated $62K sold.

MUFG Americas first reported a position in EHC in Q2 2013 and held it in 9 quarters. The position peaked at $105K in Q2 2013. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • MUFG Americas reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • MUFG Americas sold 1,383 Encompass Health shares in Q3 2022, an estimated $62K.
  • MUFG Americas first reported a position in Encompass Health in Q2 2013 and held it in 9 quarters.
  • MUFG Americas's Encompass Health position peaked at $105K in Q2 2013.
  • 346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on MUFG Americas's 13F filing for Q3 2022, filed 1 Nov 2022.